Expression of the EMT-inducing transcription factor Snail is enhanced in different human cancers. To investigate the in vivo role of Snail during progression of epithelial cancer, we used a mouse model with skin-specific overexpression of Snail. Snail transgenic mice spontaneously developed distinct histological subtypes of skin cancer, such as basal cell carcinoma, squamous cell carcinoma and sebaceous gland carcinoma. Development of sebaceous gland carcinomas strongly correlated with the direct and complete repression of Blimp-1, a central regulator of sebocyte homeostasis. Snail expression in keratinocyte stem cells significantly promotes their proliferation associated with an activated FoxM1 gene expression signature, resulting in a larger pool of Mts24-marked progenitor cells. Furthermore, primary keratinocytes expressing Snail showed increased survival and strong resistance to genotoxic stress. Snail expression in a skin-specific p53-null background resulted in accelerated formation of spontaneous tumours and enhanced metastasis. Our data demonstrate that in vivo expression of Snail results in de novo epithelial carcinogenesis by allowing enhanced survival, expansion of the cancer stem cell pool with accumulated DNA damage, a block in terminal differentiation and increased proliferation rates of tumour-initiating cells.
During tumour progression, epithelial cancer cells can undergo a dedifferentiation process and transition from a collective invasion front to disseminated migratory detachment of cells capable of spreading to distinct sites throughout the body. 1 Epithelial to mesenchymal transition (EMT) is an important step in this transition that is characterised by loss of adherence markers such as E-cadherin and increased migratory potential. Once the tumour has achieved the dedifferentiated state of single-cell dissemination, metastatic spread is increased and prognosis is exacerbated. 2 The transcription factor Snail (Snail homolog 1, Snai1) is a direct transcriptional repressor of E-cadherin 3, 4 and its overexpression in vitro and subsequent microarray analysis has clearly demonstrated its cellular reprogramming capacity and has underscored the potential role of Snail as a master regulator of EMT. 5, 6 Evidence correlating Snail to invasion has been found in many human and non-human cell lines. Although there is a large amount of in vitro data describing the role of Snail in numerous signalling cascades, one of the most important remaining challenges in the EMT field is to unravel its in vivo role in carcinogenesis and metastasis. In this respect, Snail expression has been detected in recurrent breast cancer cells with enhanced HER2/neu expression. 7 When Snail expression is blocked in human breast cancer cell lines, 8 the cells undergo a partial MET (mesenchymal to epithelial transition), and their tumourigenic behaviour in xenograft assays is reduced. The advent of well-characterised monoclonal antibodies specifically recognising Snail has been instrumental in demonstrating its expression in a wide range of epithelial tumours and in activated stromal cells surrounding the tumour. 2 Snail expression studies related to skin cancer are modest at best. Indirect evidence for a potentially important contribution of Snail has been provided by only a few studies on mice and has largely been correlative in nature. Demethylation of the Snail promoter has been observed in a multistage skin carcinogenesis model used to study epigenetic alterations coinciding with the transition from epithelial to mesenchymal morphology. 9 In other transgenic mouse models, Snai1 expression was detected downstream of Gli-1 10 and TGFbeta signalling. 11 To gain further insight into the specific in vivo role of Snail during skin cancer progression, we used a combined immunohistochemical analysis of a variety of human skin cancers along with a mouse model with skin-specific expression of an HA-tagged Snail protein. 12 Here we report for the first time that Snail transgenic mice develop spontaneous tumours: our results indicate that enhanced Snail expression contributes to the stabilisation, expansion and survival of skin stem cells in vivo, which can result in both skin tumour initiation and malignant progression for a variety of epithelialderived tumour types.
Results
Snail is expressed in different types of human skin cancer. Analysis of Snail expression has been carried out in different types of primary human cancers, including breast, colon and stomach cancer. 13 To increase our knowledge on expression of this transcription factor in skin cancer, we stained a panel of basal cell carcinoma (BCC) samples with a well-characterised monoclonal Snail antibody. 14 In all, 16 .6% of these samples were Snail-positive (Table 1) . However, Snail expression was evident only at invasive fronts, where cells seem to undergo EMT (Supplementary Figure S1) . Furthermore, we stained an additional group of 21 pathologically different skin tumours (Table 1) , 28.6% showed enhanced Snail immunoreactivity. Although we stained only a few poroma and porocarcinoma samples, many of these samples were Snail-positive. As reported previously, 14 some tumours expressed Snail in the activated stroma close to the invasive regions and occasionally in endothelial cells. These results show that a variety of human skin cancers have aberrantly activated and stabilised Snail expression in the most histologically invasive regions of these tumour samples.
Snail expression in skin induces spontaneous tumour formation. The frequent expression of Snail in a wide variety of human skin tumour samples prompted us to investigate whether Snail expression is sufficient to drive tumour progression in an in vivo mouse model. Sustained Snail expression in the basal layer of the skin leads to epidermal hyperproliferation resulting in increased epidermal thickness in K14-Snail mice. 12 Quantification of Ki-67-positive cells in Snail-positive skin further supports this enhanced proliferation rate (Figures 1a and b) .
Surprisingly, K14-Snail mice started to develop spontaneous skin tumours at the age of 5 months, with a median latency of 282 days (Supplementary Table SI) . Histological analysis of these tumours revealed three major epithelial Table SII) . Sebaceous gland carcinoma in K14-Snail mice was often mixed with SCC implying an early progenitor population that becomes transformed but still retains some differentiation characteristics (Figure 1c ).
Snail expression represses Blimp-1 and results in sebocyte amplification. One of the most frequent tumour types observed in K14-Snail animals was sebaceous gland carcinoma. Therefore, we first focused our analysis on the overall sebaceous gland morphology from the time of birth until the time of tumour formation. Staining for adipophilin, a lipid droplet-associated protein, showed that the composition of sebocytes in newborn K14-Snail mice was dramatically different from those observed in wild-type (WT) littermates (Figure 2a) . Staining with the hyperproliferation marker Keratin-6 revealed that sebocytes expressing Snail were still highly proliferative when the mice were 3 weeks old, a time when normal terminal differentiation and cessation of sebocyte proliferation is observed in WT controls. Later on, the sebaceous gland cells in transgenic mice started to accumulate and several glands per hair follicle were formed ( Figure 2b ). This disorganisation was aggravated over time and led to sebaceous gland hyperplasia and carcinoma (Supplementary Figure S2) . Sebaceous gland cells were disturbed in all K14-Snail mice, and this hyperproliferative behaviour and lack of terminal differentiation likely contributes to the high incidence of sebaceous gland carcinoma formation in the K14-Snail mice. Given the peculiar morphology of sebaceous gland cells in K14-Snail mice, we screened a set of markers associated with sebaceous gland development and maintenance by qPCR analysis on RNA isolated from epidermis of newborn and adult mice (Supplementary Figure S3) . This analysis revealed significant repression of the transcription factor Blimp-1 in K14-Snail mice (Po0,05) (Figure 2c) . A significant downregulation of Blimp-1 reporter activity was observed in the sebocyte cell line SEB-1 and the breast cancer cell line MCF7 in transient Blimp-1 promoter assays (Figure 2d ). Immunohistological analysis indeed confirmed the complete absence of Blimp-1 in the sebaceous gland of K14-Snail mice, whereas Blimp-1 expression still marked the terminally differentiated Snail-negative cells in the cornified layer (Figure 2e) . Strikingly, Blimp-1-deficient mice show enhanced proliferation and expansion of the proliferative sebocyte pool. 15 Consequently, by repressing Blimp-1, Snail contributes to the massive expansion of the sebaceous glands.
Snail expression results in aberrant FoxM1 activation and formation of aberrant spindle formation. Sebaceous gland cells are derived from stem cells from the bulge region. [16] [17] [18] We next studied in detail both stem cells and progenitors present in this region. In contrast to newborn mice, in adult K14-Snail mice the Mts24-positive progenitor population was expanded and Mts24 was retained in some sebaceous gland cells (Figure 3a) . Mts24 mRNA expression levels in adult K14-Snail mice were also significantly enhanced, reflecting the overall increased numbers of MTS24-expressing cells. In addition, the bulge stem cell marker Lgr6 was reduced in these mice (Figure 3b ). It is generally believed that clonogenic keratinocytes are closely related, if not identical, to multipotent stem cells. Therefore we compared the clonogenic capacity of CD34 þ keratinocytes derived from K14-Snail mice with their WT counterparts at the age of 8 weeks: the K14-Snail cells formed many more and much larger colonies than the WT cells (Figure 3c ). Mts24 þ progenitors also have clonogenic potential. 19 Again, we found the clonogenic potential significantly enhanced in Mts24 þ cells isolated from the K14-Snail mice (Figure 3c ). Microarray profiling of both stem cell and progenitor populations of WT and K14-Snail mice revealed the aberrant activation of FoxM1 and several downstream target genes 20 regulating cell cycle genes essential for G2/M progression, chromosomal segregation and cytokinesis (Figure 3d and Supplementary Figure S4 ). Aberrant activation of FoxM1 has been correlated with chromosomal instability. 21 Consistent with this role, we found a high number of triple spindles in synchronised K38 keratinocyte cells stably transduced with Snail compared with control cells (Figure 3e ).
Snail expression in keratinocytes promotes cell survival and resistance to genotoxic stress. To further understand the cellular role of Snail in skin tumourigenesis, and specifically its effect on cell survival and apoptosis, we isolated keratinocytes from newborn WT and K14-Snail mice. Treatment of the cells in vitro with the experimental genotoxic agent 2,4-dimethoxybenzaldehyde (DMBA) resulted in a clear survival advantage for keratinocytes expressing Snail compared with WT control cells (Figure 4a ). At lower DMBA concentrations, K14-Snail-derived cells even showed enhanced proliferation in response to DMBA exposure. Treating the cells with the chemotherapeutic drug doxorubicin, which is used clinically to treat skin cancer patients, also led to a significant survival advantage for keratinocytes with transgenic Snail expression. Assessment of caspase-3 and -7 activities during both treatments demonstrated antiapoptotic activity in cells expressing Snail (Figure 4a ). We next investigated these findings further in vivo by using the classical DMBA/TPA (12-O-tetradecanoylphorbol-13-acetate) two-stage carcinogenic protocol, a treatment known to induce rapid development of skin papillomas. In line with a similar experiment, 22 papilloma initiation was visible during week 8 of the TPA treatment. Single or multiple DMBA treatment without further promotion by TPA resulted in significantly more tumours in transgenic than in WT mice ( Figure 4b ). These experiments indicate that Snail expression on its own can synergise with DMBA treatment alone without the need for the tumour-promoting activity of TPA. As expected from macroscopic observations, the morphology of the tumours in K14-Snail transgenic mice looked different then the WT papillomas. There was a striking appearance of multiple infiltrating strands of cells spread all over the skin ( Figure 4c ) pointing to enhanced invasion. Cryosections stained with E-cadherin confirmed the histopathological analysis done with haematoxylin and eosin (H&E) staining: the dermis of DMBA-TPA-treated K14-Snail animals contained multiple small groups of epithelial cells. These cells stained E-cadherin weakly and were often E-cadherin negative (Supplementary Figure S5) . Metastatic spread to the lung, liver, spleen or peritoneum was not observed during the initial stages of these chemical carcinogenesis experiments. Overall, these data indicate that Snail, besides its role in tumour initiation, also contributes to cancer progression.
Tumour formation in Snail transgenic skin is accelerated in a p53 knock-out background. Given that keratinocytes from K14-Snail mice are more resistant to chemotoxic stress, we investigated the consequences of specifically inactivating In vitro analysis shows the significant reduction of Blimp-1 promoter activity in the presence of Snail expression in the sebocyte cell line SEB-1 (two independent experiments) and the breast carcinoma cell line MCF7 (three independent experiments). (e) Immunohistological analysis with an antibody-recognising Blimp-1 reveals the total absence of this transcription factor in the sebaceous gland of newborn and adult K14-Snail mice (presence in WT marked with arrowheads, and detail in insert-3 Â magnified). However, the characteristic staining pattern in terminally differentiated keratinocytes in the suprabasal layer (marked by arrows) is retained p53 in the skin. p53 is an important tumour suppressor that eliminates cells subjected to different forms of stress, including those exposed to DMBA/TPA protocols. We genetically intercrossed the K14-Snail mice with a tissuespecific knockout of p53, K14Cre;Trp53 f/f . 23 Although K14-Snail;K14Cre;Trp53 f/f mice do not develop significantly more tumours than K14-Snail mice alone (Figure 5a ), tumourigenesis is much more rapid, with a median latency of 176 days (Supplementary Table SI Snail expression drives malignant skin cancer progression. Aberrant expression of Snail in epithelial cancer cell lines has been reported to endow cells with enhanced invasive properties, which could contribute to the formation of metastases. 24 Sebaceous gland carcinomas in K14-Snail mice were the most highly metastatic, as draining (Figure 5c ). Given that metastasis of malignant tumours to regional lymph nodes is one of the earliest signs of cancer spread in patients, 25 we histologically examined different other organs, but we could not observe distant metastasis of sebaceous cancer cells. However, we found lung metastasis displaying features of terminal skin differentiation in mice with primary tumours resembling SCCs (Supplementary Figure S6 and Figure 5c ). As K14Cre;Trp53 f/f mice form spontaneous benign skin tumours that are non-metastatic, they are suitable for investigating the phenotypic consequences of additional mutations in genes implicated in tumour progression and metastasis. Indeed, Kaplan-Meier survival analysis indicates that Snail drives malignant progression even further as was evidenced by the overall statistically significant difference between the survival curves. Moreover, in contrast to the K14Cre;Trp53 f/f mice, K14-Snail;K14Cre;Trp53 f/f mice formed aggressive carcinosarcomas, which are highly invasive, again pointing to the contribution of the Snail nuclear protein to enhancing malignancy in synergy with p53 deficiency.
Discussion
In vitro evidence for the involvement of Snail in cancer progression has been increasing. However, little is known about the molecular mechanism of Snail's contribution to the early onset of epithelial cancer in vivo and particularly its role in skin cancer progression. Therefore, we studied the cellular and molecular consequences of Snail expression in the basal layer of the skin.
K14-Snail mice develop spontaneous skin tumours of different histological subtypes, of which sebaceous gland carcinoma is one of the most prominent. In the sebaceous compartment, we have observed a continuous expansion of a population of cells leading to sebaceous hyperplasia and eventually sebaceous carcinoma with metastatic spread to the lymph nodes. The intense sebocyte proliferation and glandular growth can be explained by the continuous proliferation and expansion of the enlarged Mts24 þ progenitor population and the loss of Blimp-1-positive sebaceous cells. The transcriptional repressor Blimp-1 marks the terminally differentiated region of the sebaceous gland. 26 We found that loss of Blimp-1 in the sebaceous gland is one of the earliest molecular consequences of Snail expression in the skin. Furthermore, SCD3, another marker for terminal sebocyte differentiation, was downregulated in K14-Snail mice compared with WT mice (data not shown). Snail directly represses Blimp-1 promoter activity in the sebocyte cell line SEB-1. In agreement with our findings, conditional Blimp-1 ablation in the skin results in enhanced sebocyte proliferation. 15 Collectively, these data indicate that the gatekeeper of sebaceous gland homeostasis, Blimp-1, is a direct target of Snail.
In addition to sebaceous gland carcinoma development, we also observed tumours resembling BCCs. We were able to show local, Snail-positive regions in a subset of human BCCs. Complementary to our data, conditional expression of Gli1 in mouse skin induces hyperplastic lesions evolving into BCC. 27 In these mice, Snail transcripts were detected as an early response to enhanced Gli1 activity, suggesting that Snail could functionally contribute to tumour initiation. Moreover, our data indicate that Snail is not only implicated in the early onset of the tumours but also contributes to invasiveness, as has been observed in a subset of human BCCs. Finally, we found cutaneous SCC among the spontaneous tumours that arose in K14-Snail mice. This common cancer typically arises from malignant proliferation of keratinocytes in the epidermis and is characterised by invasive growth and presence of keratin pearls. It was previously demonstrated that Snail knockdown in the squamous carcinoma HaCa4 cell line has a large effect on cellular invasiveness, tumour growth and metastasis. 28 In contrast to BCC, SCC can metastasise in humans. Indeed, in mice with primary SCCs we identified metastatic lung nodules displaying distinct features of skin differentiation. This is a strong indicator that the cancer dissemination is fuelled by Snail-expressing cancer stem cells derived from the skin, which have not lost their ability to establish organised structures at distant sites. Likewise, it has been proposed that in colorectal cancer EMT is involved in primary tumour progression and that subsequent redifferentiation (MET) takes place towards an epithelial phenotype in metastases. Skin is a very plastic organ and several of its cell populations seem to have stem cell properties. 30 Both CD34 þ and Mts24 þ keratinocytes derived from K14-Snail mice have a much higher clonogenic potential than WT keratinocyte stem cell populations, leading us to conclude for the first time that Snail has an important role in vivo in the expansion of stem cell and progenitor cell populations that lack the ability to terminally differentiate normally, explaining sebaceous gland hyperplasia and eventually sebaceous gland carcinoma in K14Snail mice. However, given the different tumour types that we have observed we postulate Snail involvement in distinct activated stem cell populations. Although it has been shown that differentiated epithelial breast cell lines acquire cancer stem cell characteristics such as the ability to grow in semi-solid medium and form mammospheres when they express Snail, 31 we here provide the first in vivo evidence for the oncogenic potential of Snail to enhance the CD34 þ cancer stem cell population of the skin. It is clear as well from our analysis that Snail activates FoxM1 expression and its downstream target genes. It has been shown that FoxM1 upregulation induces genomic instability in epidermal keratinocytes. 21 We also show that cells expressing Snail in a malignant context have an increased resistance to genotoxic and other forms of stress. This survival advantage has been previously demonstrated in the recurrence of breast cancer accompanied by an EMT phenotype and strong expression of Snail. 7, 32 Moreover, Snail expression results in increased radioprotection in transgenic CombitTA-Snail mice. 33 These observations are complementary to our data here in the skin demonstrating that Snail-expressing keratinocytes are more resistant to apoptosis, and that they even gain a proliferative advantage when subjected to chemical carcinogens or chemotherapeutics. Consequently, K14-Snail mice form more tumours when subjected not only to the classical DMBA/TPA protocols, which confirms the observations of Due et al., 22 but also when subjected to one or more DMBA treatments without further promotion. This is a very strong indicator that Snail maintains the proliferation and tumour-promoting activity necessary for the expansion of the initiated cells during tumour promotion.
The tumour-suppressor p53 has an integral role in cellular responses to DNA damage, but there is also substantial evidence that p53 deficiency facilitates reprogramming of differentiated cells. 34 Moreover, p53 loss rescues epidermal stem cell function in telomerase-deficient mice. 35 In K14-Snail; K14Cre;Trp53 f/f mice, we found not only the tumour types observed in K14-Snail mice, but carcinosarcomas as well, which is an indication of greater plasticity observed through the combined loss of p53 and Snail overexpression. Our data suggest that the combination of Snail expression and loss of p53 is probably an important trigger for this tumour type that may also potentially need the accumulation of additional critical mutations. Besides the formation of carcinosarcomas in K14-Snail;K14Cre;Trp53 f/f mice, tumour onset and lung metastasis were dramatically enhanced. The increase in lung metastases in this combinatorial model may also be due not only to a more rapid outgrowth of lung micrometastasis but also to lung nodules arising from the carcinosarcomas, which are a much more aggressive tumour than those formed by increased metastasis of SCCs.
In summary, our data show that expression of the transcriptional repressor Snail is involved in the onset and progression of tumour formation in skin at several different levels (see Summary model in Figure 6 ). At onset, Snail expression affects the in vivo proliferative capacity of keratinocytes leading to a block in the terminal differentiation of specific sub-populations of progenitors, such as Blimp-1 as direct target in sebocytes. We have demonstrated for the first time in vivo that Snail expression in addition to its role in EMT is also linked to the expansion of CD34 þ stem cell populations in the skin through ex vivo clonogenic assays. In addition, as populations of non-terminally differentiated cells accumulate genetic mutations, for example, by aberrant activation of FoxM1, Snail appears to lead to intrinsic protection of these cells that allows their survival and further accumulation of genomic aberrations allowing the progression to carcinoma. At this stage, Snail's widely reported in vitro function as inducer of EMT comes into play enabling the cells to invade and migrate, which eventually leads to metastasis. 
Material and Methods
Tumour analysis. Experiments were done in accordance with the institutional guidelines regarding the care and use of laboratory animals. K14-Snail, K14Cre;Trp53 f/f and K14-Snail;K14Cre;Trp53 f/f mice were killed as soon as the spontaneous tumours reached 15 mm 3 or sooner if they were suffering from tumour burden. Tumours and organs were either snap-frozen in liquid nitrogen for further analysis or fixed in 4% paraformaldehyde, processed and embedded in paraffin for histological studies. H&E or antibody staining on paraffin sections were carried out using standard procedures as described below. Tumours were scored and classified independently by two scientists, and their consensus is presented in the tables. Human tumour biopsies were obtained from surgical excisions of the affected areas at the Department of Dermatology, University of Cologne, Cologne, Germany. The patients signed the informed consent from the Department of Dermatology, University of Cologne, approved by the Institutional Commission of Ethics (Az.08-144). The study was conducted according to the Declaration of Helsinki Principles. The tumour data set contain 30 BCCs, 6 poroma/ porocarcinomas, 4 sebaceous gland carcinomas and 2 trichoblastomas. In addition, we stained four microcystic adnex carcinomas, three melanomas and two trichoepitheliomas, which all turned out to be Snail negative.
Carcinogenesis protocols. Experiments were done in accordance with the institutional guidelines regarding the care and use of laboratory animals. For twostage chemical carcinogenesis, we shaved the backs of 8-week-old mice using a Wella Contoura hair clipper (Wella, Bio Services, Uden, The Netherlands) and treated them 2 days later with a single application of DMBA (25 mg in 200 ml acetone) (Sigma, Diegem, Belgium; cat. no. D-3254). One week later, we started biweekly applications of TPA (200 ml of 10 À 4 M solution in acetone) (Fluka, Sigma, cat. no. 79346) for 12 weeks. We visually examined the mice weekly. Mice were shaved in week 3 and week 6 (before papilloma formation) to allow better distribution of the chemicals on the skin. Ten WT and ten Snail transgenic littermates were treated with the DMBA/TPA protocol. Another five mice got only DMBA treatment and were treated further only with the vehicle, acetone. In addition, eight mice were treated with DMBA two times per week for 8 weeks. Two WT mice and two K14-Snail transgenic mice were treated with acetone both at the initiation step and in the subsequent promotion steps. Tumours and organs were processed as described above.
Immunohistochemistry. Tumours and organs were isolated and fixed overnight in 4% paraformaldehyde solution, processed and cut into 6-mm sections. For histology, samples were stained with H&E. For immunohistochemical staining, antigen retrieval was done in citrate buffer and endogenous peroxidases were blocked with 3% H 2 O 2 . The sections were incubated with primary antibodies and stained with biotin-conjugated secondary antibodies followed by Streptavidin-HRP (substrate development with DAB) or Streptavidin Alexa Fluor. When necessary, the signal was amplified using the Tyramide Signal Amplification (TSA) kit (Perkin Elmer, Zaventem, Belgium).
The following antibodies were used: mouse anti-Snail (1/80), 14 mouse anti-HAtag (1/1000) (Babco, Eurogentec, Seraing, Belgium; cat. no. MMS-101R), rat antiKi-67 (1/30) (Dakopatts, Dako Belgium, Leuven, Belgium; cat. no. M 7249), rabbit anti-Blimp-1 (1/3000), 36 guinea pig anti-adipophilin (1/3000) (Fitzgerald Industries International, Concord, MA, USA; cat. no. RDI-PROGP40), rat anti-E-cadherin (1/ 1000) (Sigma U-3254), rabbit anti-cytokeratin 14 (1/3000) (Babco/Covance Res. Prod., Eurogentec, cat. no. PRB-155P), rabbit anti-filaggrin 14 (1/1000) (Babco/ Covance Res. Prod. cat. no. PRB-417P), rabbit anti-involucrin 14 (1/5000) (Babco/ Covance Res. Prod. cat. no. PRB-140C) rat anti-Plet-1 (1/60) 37 and mouse anti-alpha-tubulin antibody (1/100) (Pierce, Fisher Scientific, Doornik, Belgium; MA1-19162).
Keratinocyte culture. Pups were decapitated at the age of 2 days, and their limbs and tail were removed. A tail tip was kept aside for genotyping. The body was subsequently disinfected in isobetadine and washed twice in 70% ethanol and three times in PBSA containing 250 mg/ml gentamycin. The skin was carefully dissected and incubated for at least 30 min in PBSA containing 250 mg/ml gentamycin. The skins were spread in a petridish (dermis down), and sufficient dispase II solution was added to allow the skins to float on the solution. Dispase II solution was prepared by dissolving 2.5 U/ml dispase II in Ca 2 þ -free keratinocyte medium (Clonetics, Lonza, Verviers, Belgium; cat. no. CC-3112) without serum. After overnight incubation at 4 1C, the dispase II solution was removed, and the epidermis was separated from dermis. The epidermis was cut in pieces and incubated for 10 min in a 5 Â trypsin/EDTA solution (Gibco, Life Technologies, Gent, Belgium; cat. no. 15400-054, diluted in PBSA) at 37 1C on a rotation wheel. The tubes were shaken vigorously to dissociate the cells from clumps. FCS was added to the suspension, and the cells were filtered through 70-mm strainers to remove the remaining clumps. Cells were centrifuged (7 min at 1250 r.p.m.), resuspended in Ca 2 þ -free keratinocyte medium with 10% FCS, centrifuged again (7 min at 1250 r.p.m.) and resuspended in Ca 2 þ -free keratinocyte medium with 10% FCS. The cells were counted, plated at 1.4 Â 10 5 cells/cm 2 and incubated at 37 1C in a humidified incubator with 5% CO 2 . The next day, the medium was replaced with Ca 2 þ -free keratinocyte medium without serum. The cells were maintained by changing the medium every second day with Ca 2 þ -containing keratinocyte medium (Clonetics cat. no. CC-3111). Genotyping of pups was done with specific sequences spanning the HA-tagged region of the Snail sequence: forward primer 5 0 -CGGCGCCGTCGTCCTTCTCG-3 0 and reverse primer 5 0 -ACGCATAATCTGGTACATCATAA-3 0 . Preparation of keratinocytes of adult mice followed the same procedure, with slight modifications: the back skins of adult mice were incubated overnight on a 1 Â trypsin solution (Gibco BRL cat. no. 25050-014) instead of dispase II solution, and incubation in trypsin/EDTA at 37 1C on a rotation wheel was omitted from the following steps. For clonogenic assays, we followed a published protocol.
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CD34-positive cells were selected with a biotinylated CD34 antibody (eBioscience, Vienna, Austria; cat. no. 13-0341-85) using the easySEP mouse biotin kit (Stem Cell Technologies, Grenoble, France; cat. no. 18556) and easySEP magnet (Stem Cell Technologies, cat. no. 18000) following the manufacturer's instructions. Mts24-positive cells were selected using a specific antibody 37 followed by incubation with an anti-rat PE-labelled secondary antibody (BD Biosciences, Becton Dickinson Benelux, Erembodegem, Belgium; cat. no. 550767). Cells were then purified further using the easySEP mouse PE kit (Stem Cell Technologies cat. no. 18554) and easySEP magnet, following the manufacturer's instructions. Cells from WT and K14-Snail mice were seeded at equal densities on 3T3J2 feeder layers and maintained in custom DMEM:Ham F12 medium (3 : 1) without Ca 2 þ (Genaxxon, Ulm, Germany) for 2 weeks at 32 1C in 8% CO 2 . Cells were fixed with 4% paraformaldehyde and stained with a 1% Nile blue (Sigma cat. no. N-5632) and 1% Rhodamine B (Sigma cat. no. R-6626) solution.
Microarray analysis. Keratinocytes from 8-week-old WT and K14-Snail mice were sorted for CD34 and Mts24 as described above. RNA was prepared with TRIsure (Bioline, GC Biotech, Alphen aan den Rijn, The Netherlands; cat. no. BIO-38032), and after quality check with the NanoDrop spectrophotometer and the Agilent 2100 Bioanalyser, Affymetrix mouse gene 1.0 ST arrays were hybridised following the manufacturer's instructions at the Nucleomics VIB facility (Leuven, Belgium). Data analysis comprised looking for differentially expressed genes (at least two-fold) between positive versus negative fractions for CD34 and Mts24 for both WT and K14-Snail mice. Differentially expressed genes were imported into IPA (Ingenuity Systems, Redwood City, CA, USA) to uncover the underlying modulated pathways.
Real-time qPCR analysis. RNA was extracted from K14-Snail and WT control mice at the ages of 4 days (n ¼ 4) and 4 months (n ¼ 5) as follows. Mice were killed by cervical dislocation, and the hair was removed from old mice using a Wella Contoura hair clipper. Skin was dissected from the back and incubated the dermis down on 0.5 M ammonium thiocyanate (Sigma-Aldrich cat. no. 431354) for 30 min at 37 1C. Epidermis was then easily separated from the dermis. Epidermis was diced into very small pieces using sterile scalpels and transferred to TRIsure (Bioline cat. no. BIO-38032), shaken very well and centrifuged at maximum speed in a table-top centrifuge.
RNA was extracted from the supernatant according to the manufacturer's instructions. RNA was treated with 1 U of RNAse-free DNase RQ1 (Promega, Leiden, The Netherlands; cat. no. M6101) per 1 mg RNA for 30 min at 37 1C in appropriate buffer. DNAse was inactivated by incubation in Promega's stop solution for 10 min at 65 1C. Bulk Mg 2 þ was removed by using Amicon ultra 0.5-ml centrifugal filters (Millipore, Brussels, Belgium; cat. no. UFC510096) in two consecutive diluting washes. cDNA synthesis was performed with iScript (Bio-Rad, Eke, Belgium; cat. no. 170-8891) following the manufacturer's instructions.
Quantitative PCR was done using the Fast SYBR master mix kit (Applied Biosystems, Life Technologies, Gent, Belgium; cat. no. 4385618) for the genes of interest and reference genes Rpl13a and Actb. Primers were designed using Primer Express 1.0 Software (Perkin Elmer; Applied Biosystems). Plates were run on the LightCycler 480 (Roche, Vilvoorde, Belgium). The average threshold cycle of triplicate reactions was used for all subsequent calculations using the deltaC T method. Graphs represent the average normalised relative expression values of K14-Snail and WT mice, with the WT average normalised relative expression value at 4 days set to 1. The following primer sequences were used in this study: For the proliferation assay with MTT, the medium was refreshed 2 days after treatment, and MTT stock solution (5 mg/ml, dissolved in PBSA) (Sigma cat. no. M-2128) was added (1/5 ratio MTT solution to medium). Plates were incubated for 2 h at 37 1C. After discarding the supernatant, DMSO was added to the wells and pipetted up and down several times to allow the converted dye to dissolve completely. The solution was transferred to a 96-well plate for measurement in a Benchmark microplate reader (Bio-Rad) at 595 nm with background subtraction at 655 nm. Caspase activity was measured with Caspase-Glo 3/7 assay (Promega cat. no. G8092) 1 day after treatment, following the manufacturer's protocol.
Generation and synchronisation of K38 cells. K38 cells (stable primary mouse keratinocytes) were maintained as described. 39 Cells were transduced with lentiviral constructs allowing expression of Snail (pdWPI-mSnail) or luciferase (pdWPI-Luc) and sorted for EGFP to have a homogeneous expressing population. Cells were synchronised with thymidine-nocodazole (mitotic block): cells were treated for 24 h with 2 mM thymidine (Sigma cat. no. T9250), washed with PBS salt solution and allowed to be released from S-phase block by incubation in regular medium for 3 h. Next, cells were treated with nocodazole (10 ng/ml medium) (Sigma cat. no. M1404) for 12 h. Cells were washed with PBS and incubated in regular medium to allow their release.
Statistical analysis. Data analysis was performed using the GraphPad Prism 5 software (La Jolla, CA, USA).
Reporter assays. Transient transfection of SEB-1 40 and MCF7 cell lines was performed using the FuGENE6 reagent (Roche cat. no. 1814443). Cells were seeded the day before transfection (40 000 cells/well in a 24-well plate). Cells were transiently transfected with the 1921 bp upstream Blimp-1 promoter sequence followed by a luciferase reporter (p1921) 41 and co-transfected with an expression plasmid for hSnail (pEF6-hSnail) or an empty vector control (pEF6/myc-His A (Invitrogen, Life Technologies, Gent, Belgium). Lysates for further analysis were made 96 h after transfection using GalactoStar lysis buffer (Tropix, Life Technologies, Gent, Belgium; cat. no. T1014). Luciferase activity was measured using a luciferase substrate buffer (40 mM Tricine, 2.14 mM (MgCO 3 ) 4 Mg(OH) 2 .5H 2 O, 5.34 mM MgSO 4 .7H 2 O, 66.6 mM DTT, 0.2 mM EDTA; the solution was filtered through a Millipore glass filter. Then we added 521.2 mM coenzyme A, 734 mM ATP and 940 mM luciferine. Transfection normalisation was done by measuring betagalactosidase (GalactoStar kit, Tropix), which was encoded by cotransfected plasmids containing a beta-actin and RSV promoter upstream of a LacZ cassette.
